The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The role of serotonin in the pathophysiology and treatment of schizophrenia
Abstract
The concept of "balanced serotonergic/dopaminergic antagonists" reflects renewed interest in the role of serotonin (5-HT) in schizophrenia. Postmortem brain tissue analysis, cerebrospinal fluid studies, and pharmacological challenges suggest a deficit in 5-HT function in the cortex of patients with schizophrenia. In contrast, however, 5-HT2 antagonism is claimed to have beneficial effects on both positive and negative symptoms of the illness. The authors attempt to resolve this paradox with a model that takes into account the suggestion of a cortical serotonergic hypofunction and a beneficial effect of 5-HT2 antagonism via modulation of subcortical dopamine activity. Although involvement of 5-HT in schizophrenia is supported by compelling evidence, more research is needed to better define its role in pathophysiology and treatment of this illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869
Titeler, M., Lyon, R. A., & Glennon, R. A. (1988) · Psychopharmacology · doi:10.1007/bf00176847 · Cited by 343
Cited by
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
The Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 662
Brezun, J. M., & Daszuta, A. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00693-9 · Cited by 549
A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei
Pollak Dorocic, I., Fürth, D., Xuan, Y., Johansson, Y., Pozzi, L., Silberberg, G., Carlén, M., & Meletis, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.002 · Cited by 451
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391
Kaar, S. J., Natesan, S., McCutcheon, R., & Howes, O. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 383
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
MEYER, U., FELDON, J., & DAMMANN, O. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212c196 · Cited by 357
“For example, similar to a subset of schizophrenia patients, some individuals with autism display abnormal serotonin synthesis capacity and serotonin receptor dysfunctions (21,22).”
Polesskaya, O. O., & Sokolov, B. P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10173 · Cited by 277
Dawson, L. A., & Watson, J. M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00067.x · Cited by 262
Meyer, U., Schwarz, M. J., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 258
Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242
Zhuang, Z., Yang, R., Wang, W., Qi, L., & Huang, T. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01961-8 · Cited by 220
Feng, J., Cai, X., Zhao, J., & Yan, Z. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06502.2001 · Cited by 212
Neural basis of psychosis-related behaviour in the infection model of schizophrenia
Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158
Gillin, J. C., Buchsbaum, M., Wu, J., Clark, C., & Bunney, W. (2001) · Depression and Anxiety · doi:10.1002/da.1045 · Cited by 103
Yan, Z. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:203 · Cited by 100
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Cai, X., Flores‐Hernandez, J., Feng, J., & Yan, Z. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013391 · Cited by 97
Acute serotonin and dopamine depletion improves attentional control: findings from the Stroop task
Scholes, K. E., Harrison, B. J., O'Neill, B. V., Leung, S., Croft, R. J., Pipingas, A., Phan, K. L., & Nathan, P. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301262 · Cited by 86
Region-specific alteration of GABAergic markers in the brain of heterozygous reeler mice
Nullmeier, S., Panther, P., Dobrowolny, H., Frotscher, M., Zhao, S., Schwegler, H., & Wolf, R. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07563.x · Cited by 43
Tipper, C. M., Cairo, T. A., Woodward, T. S., Phillips, A. G., Liddle, P. F., & Ngan, E. T. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0025-4 · Cited by 34
Metadata
- Venue
- The Journal of Neuropsychiatry and Clinical Neurosciences
- Published
- 1997-02-01
- Volume
- 9
- Issue
- 1
- Pages
- 1-17
- ISSN
- 0895-0172 (ISSN-L)
- 1545-7222
- OpenAlex
- W2412909457
- Cited by
- 211
- References
- 5
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.